{"_buckets": {"deposit": "b8852285-3278-4d8d-a603-2432984c2586"}, "_deposit": {"created_by": 3, "id": "1248", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "1248"}, "status": "published"}, "_oai": {"id": "oai:dmu.repo.nii.ac.jp:00001248", "sets": ["71"]}, "author_link": ["6159"], "item_2_biblio_info_12": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2014-10-25", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3", "bibliographicPageEnd": "323", "bibliographicPageStart": "315", "bibliographicVolumeNumber": "41", "bibliographic_titles": [{"bibliographic_title": "Dokkyo journal of medical sciences"}]}]}, "item_2_description_10": {"attribute_name": "抄録(日)", "attribute_value_mlt": [{"subitem_description": "自己免疫疾患の治療は生物学的製剤の導入により膠原病の治療は大きく変化した.特に関節リウマチ(RA)においては,抗サイトカイン療法は従来実現が困難であった関節破壊の防止を可能とし,RA の治療目標,治療戦略さらには診断基準の変更をもたらし,患者のQOL を劇的に改善した.本稿は基礎的研究からはじまった抗サイトカイン療法がRA 診療をいかに変えたかを述べることで,translational study の重要性を示したい.", "subitem_description_type": "Other"}]}, "item_2_description_15": {"attribute_name": "表示順", "attribute_value_mlt": [{"subitem_description": "15", "subitem_description_type": "Other"}]}, "item_2_description_16": {"attribute_name": "アクセション番号", "attribute_value_mlt": [{"subitem_description": "KJ00009545212", "subitem_description_type": "Other"}]}, "item_2_description_8": {"attribute_name": "記事種別(日)", "attribute_value_mlt": [{"subitem_description": "特集", "subitem_description_type": "Other"}]}, "item_2_source_id_1": {"attribute_name": "雑誌書誌ID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00629581", "subitem_source_identifier_type": "NCID"}]}, "item_2_source_id_19": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "03855023", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_6": {"attribute_name": "著者所属(日)", "attribute_value_mlt": [{"subitem_text_value": "獨協医科大学リウマチセンター"}]}, "item_2_title_3": {"attribute_name": "論文名よみ", "attribute_value_mlt": [{"subitem_title": "セイブツガク テキ セイザイ ワ カンセツ リウマチ ノ リンショウ オ イカ ニ カエタカ トクシュウ アレルギー メンエキ チリョウ ノ サイシンノ シンポ"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "倉沢, 和宏"}, {"creatorName": "クラサワ, カズヒロ", "creatorNameLang": "ja-Kana"}], "nameIdentifiers": [{"nameIdentifier": "6159", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-05-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KJ00009545212.pdf", "filesize": [{"value": "736.2 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 736200.0, "url": {"label": "KJ00009545212.pdf", "url": "https://dmu.repo.nii.ac.jp/record/1248/files/KJ00009545212.pdf"}, "version_id": "065cbb1e-75db-4132-aee2-041091fc531b"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "関節リウマチ", "subitem_subject_scheme": "Other"}, {"subitem_subject": "生物学的製剤", "subitem_subject_scheme": "Other"}, {"subitem_subject": "抗サイトカイン療法", "subitem_subject_scheme": "Other"}, {"subitem_subject": "治療戦略", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "生物学的製剤は関節リウマチの臨床をいかに変えたか (アレルギー免疫治療の最新の進歩)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "生物学的製剤は関節リウマチの臨床をいかに変えたか (アレルギー免疫治療の最新の進歩)"}, {"subitem_title": "The Revolution in Rheumatoid Arthritis Management by Biologics Centre for Rheumatic Disease", "subitem_title_language": "en"}]}, "item_type_id": "2", "owner": "3", "path": ["71"], "permalink_uri": "https://dmu.repo.nii.ac.jp/records/1248", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-05-24"}, "publish_date": "2017-05-24", "publish_status": "0", "recid": "1248", "relation": {}, "relation_version_is_last": true, "title": ["生物学的製剤は関節リウマチの臨床をいかに変えたか (アレルギー免疫治療の最新の進歩)"], "weko_shared_id": 3}